Product: Eviti


Thought Leadership



Eviti Connect On-Demand Webinar titled Biosimilars in Cancer Care: A Guide for Payers
On Demand Eviti Webinar—Biosimilars in Cancer Care: A Guide for Payers
Strategic use of biosimilars in cancer care provides an opportunity for more value as these drugs frequently cost less than...
Eviti Connect
Eviti Connect Product VIdeo Still: Enabling High-Quality, High-Value Care
Enabling High-Quality, High-Value Care
As oncology costs continue to escalate and treatment decisions are more complex than ever, Eviti Connect empowers providers and payers...
Eviti Connect
Eviti Advisor Product VIdeo Still: Evidence-based Treatment Intelligence for Improved Outcomes
Evidence-based Treatment Intelligence for Improved Outcomes
Many factors go into making an informed treatment decision. Eviti Advisor supports physicians in the treatment decision process using a...
Eviti Advisor
zoomed in highly detailed image of eye showing color of iris
Patient-Centered Cancer Care: New Treatments and Defining Quality
Oncology has a lot on its plate. As cancer care is welcoming a bounty of new treatments, it is absorbing...
Emerging Technologies and their impact on Patient-Centric Care hero graphic illustration with blue light flowing out of computer chip
Emerging Technologies and Their Impacts on Patient-Centric Care
With many new emerging technologies in healthcare, we look at how these technologies impact patient-centric care. Learn more from NantHealth...
The Center for Biosimilars: The Top 5 Biosimilar Articles From SABCS 2020
The 2020 San Antonio Breast Cancer Symposium (SABCS) was held from December 8 to December 12, 2020. During the virtual...
Eviti Product VIdeo Still: The Patient Journey Through Eviti
The Patient Journey Through Eviti
Navigating the unknowns of a new diagnosis and treatment plan can be stressful – that’s where Eviti comes in. With...
Health Professional Radio: Breast Cancer Treatment—Trastuzumab Biosimilars
Dr. William Flood, Chief Medical Officer for Eviti at NantHealth, discusses new significant findings from Eviti Connect, presented at the...
Mark Mozley, Senior Vice President, Global Sales & Marketing
The Promise of Real-World Data in Healthcare
The challenges of last year tested all of us. Whether you were like me and adjusting to homeschooling your children...
Eviti Advisor
Thrive Global: Dr. Tiffany Avery of NantHealth—“Ensuring that Everyone has Access to Healthcare is Essential”
Ensuring that everyone has access to healthcare is essential. Access should be coupled with an emphasis on screening and prevention...
Eviti Advisor
Eviti Connect On-Demand Webinar titled Oncology Treatment Plan Validation: What is it and Why is it Important?
On Demand Eviti Webinar—Oncology Treatment Plan Validation
The cost of oncology-focused drugs in the U.S. has now exceeded $56 billion and the median annual expense of a new cancer...
Eviti Connect
Eviti Connect
NantHealth Presents Significant Treatment Insights at the 2020 San Antonio Breast Cancer Symposium in a Time of Need with the...
NantHealth’s study data shows: Adoption of trastuzumab biosimilars in treatment of HER2-positive breast cancer is significant; does not appear to...
Eviti Connect